A long-term survivor of recurrent esophagogastric junction adenocarcinoma treated with multidisciplinary therapy: a case report

Tanaka, Takako; Arigami, Takaaki; Uenosono, Yoshikazu; Yanagita, Shigehiro; Matsushita, Daisuke; Okubo, Keishi; Kijima, Takashi; Uchikado, Yasuto; Kita, Yoshiaki; Mori, Shinichiro; Sasaki, Ken; Omoto, Itaru; Kurahara, Hiroshi; Maemura, Kosei; Ishigami, Sumiya; Natsugoe, Shoji

doi:10.1186/s40792-020-0776-5

Surgical Case Reports

Table 1 Reported case of resected lung metastasis from gastric cancer in Japan

From: A long-term survivor of recurrent esophagogastric junction adenocarcinoma treated with multidisciplinary therapy: a case report

Year	Author	Age	Sex	Depth of invasion	Pathological stage	N	Histological type	Type of gastrectomy	Disease-free interval	Adjuvant chemotherapy	Number of pulmonary metastases	Metastatic lesion	Outcome after gastrectomy
2002	Inoue et al. [5]	68	M	sm	Stage Ia	N0	tub1	DG	8 years	Unknown	1	Lung	A (15 years)
2002	Tamura et al. [6]	67	M	ss	Stage IIA	N1	tub2	TG	5 years, 8 months	Unknown	1	Lung Brain	D (6 years, 2 months)
2002	Tamura et al. [6]	47	M	se	Stage IIIA	N1	tub2	TG	4 years, 1 month	Unknown	1	Lung Chest wall	D (5 years, 7 months)
2002	Tamura et al. [6]	73	M	se	Stage IIIA	N1	muc	TG	2 years	Unknown	1	Lung Liver	D (2 years, 7 months)
2002	Tamura et al. [6]	65	M	mp	Stage IB	N0	tub2	TG	7 months	Unknown	1	Lung Brain	D (1 year, 7 months)
2007	Sakaguchi et al. [7]	67	F	si	Stage IIIA	–	pap	TG	4 years, 1 month	5FU + CDDP	1	Lung	A (10 years, 5 months)
2007	Sakaguchi et al. [7]	75	M	mp	Stage IB	–	pap	DG	5 years	Unknown	1	Lung	A (7 years, 9 months)
2007	Sakaguchi et al. [7]	57	M	ss	Stage II	–	tub2	DG	4 years	Unknown	1	Lung	A (5 years, 9 months)
2007	Sakaguchi et al. [7]	75	M	sm	Stage IB	–	tub2	TG	4 years	Unknown	1	Lung	A (4 years, 8 months)
2007	Sakaguchi et al. [7]	57	F	ss	Stage IB	–	tub2	TG	1 years, 8 months	S-1	1	Lung	A (3 years, 5 months)
2007	Sakaguchi et al. [7]	76	F	ss	Stage II	–	tub1	TG	0 months	Unknown	1	Lung	D (4 years, 11 months)
2007	Sakaguchi et al. [7]	84	M	ss	Stage IB	–	tub1	TG	19 months	Unknown	1	Lung	D (1 year, 10 months)
2009	Nishioka et al. [8]	40	M	se	Stage IIIA	N1	pap	PG	4 years	S-1 + CPT11	2	Lung	A (7 years)
2012	Harada et al. [2]	55	M	se	Stage II	N0	tub2	TG	3 years	S-1	2	Lung Adrenal gland	A (6 years, 9 months)
2012	Shimoyama et al. [9]	55	M	si	Stage IV	N3	tub2	DG	7 years, 2 months	Unknown	1	Lung	A (8 years, 5 months)
2012	Shimoyama et al. [9]	77	M	ss	Stage II	N1	tub1	DG	5 years	Unknown	1	Lung	D (9 years, 8 months)
2012	Shimoyama et al. [9]	76	M	ss	Stage II	N1	tub2	TG	3 years, 7 months	Unknown	1	Lung Liver Brain	D (4 years, 11 months)
2012	Shimoyama et al. [9]	80	M	ss	Stage IB	0	tub2	TG	1 year, 6 months	Unknown	3	Lung	D (3 years, 8 months)
2019	Our case	51	M	sm	Stage IB	N1	muc	TG	1 years, 5 months	S-1, cape+CDDP+Trastuzumab	1	Lung	A (8 years, 4 months)

sm submucosa, si invasion of adjacent structures, mp muscularis propria, se serosa exposed, ss subserosa, tub1 well-differentiated tubular adenocarcinoma, pap papillary adenocarcinoma, tub2 moderately differentiated tubular adenocarcinoma, muc mucinous adenocarcinoma, DG distal gastrectomy, TG total gastrectomy, PG proximal gastrectomy, 5FU fluorouracil, CDDP cisplatin, cape capecitabine, CPT11 irinotecan, A alive, D dead

Back to article page